CN1136899C - Chinese medicine for treating mastoplasia - Google Patents
Chinese medicine for treating mastoplasia Download PDFInfo
- Publication number
- CN1136899C CN1136899C CNB011253142A CN01125314A CN1136899C CN 1136899 C CN1136899 C CN 1136899C CN B011253142 A CNB011253142 A CN B011253142A CN 01125314 A CN01125314 A CN 01125314A CN 1136899 C CN1136899 C CN 1136899C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- rhizoma chuanxiong
- medicine
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 239000012567 medical material Substances 0.000 claims description 21
- 241000195474 Sargassum Species 0.000 claims description 18
- 241001250596 Pleione Species 0.000 claims description 17
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract 2
- 210000005075 mammary gland Anatomy 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000002775 capsule Substances 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 208000030270 breast disease Diseases 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- -1 Radix Bupleuri Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a traditional Chinese medicine formula for treating hyperplasia of mammary glands, which is mainly prepared from hemlock parsley, cassia twig, asarum herb, dahurian angelica, rhizoma pleionis, Fritillariae Thunbergii Bulbus, selfheal spike, herba agastachis, angelica, oyster and seaweed. Simultaneously, other medicinal materials can be added to the formula according to different symptoms. The formula has the advantages that the purposes of improving the metabolism of human bodies and eliminating stasis accumulation in vivo are achieved by supplementing and nourishing qi and blood, softening and resolving hard mass, and activating blood circulation to dissipate blood stasis; pain caused by hyperplasia of mammary glands can be relieved by regulating qi for relieving pain; Chinese herbal medicines are used as raw materials, so that toxic and side effects can be avoided; the effective rate is 93% according to clinical tests of more than 1000 examples; a medicine prepared by the formula is convenient to take and has the advantage of low cost. Thereby, the formula is suitable for common people.
Description
(1) technical field: the present invention relates to medicine, further is the medicine that is used for the treatment of cyclomastopathy, is particularly useful for treating the Chinese Traditional Medicines of cyclomastopathy.
(2) background technology: cyclomastopathy refers to the block not of uniform size of generation in the breast, belonging to the non-inflammation mastopathy, is modal breast disease among the women, accounts for whole mastotic 2/3rds, the medicine of multiple treatment cyclomastopathy is arranged in the market, and effect has nothing in common with each other.Recently " the breast peace sheet " sold on the market adopts 10 kinds of traditional Chinese medicines such as the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Radix Asparagi, the Radix Astragali, Radix Bupleuri, Olibanum, Herba Epimedii, Endothelium Corneum Gigeriae Galli to make, and the concrete quantity of each medical material is not quite clear.
(3) summary of the invention: the objective of the invention is to be to provide a kind of Chinese patent medicine formula for the treatment of cyclomastopathy, the medicine that adopts this method to produce, result of use is good.
The objective of the invention is to realize: a kind of medicine for the treatment of cyclomastopathy by following scheme, mainly by Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, compatibility forms, more than each medical material, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.5～1.5,0.5～1.5,0.5～1.5,0.5～1.5,1～3,1～3,1～3,1～3,7～9,7～9.
Among the present invention, Concha Ostreae can replace with Concha Meretricis Seu Cyclinae or Concha Arcae, and Sargassum can replace with Thallus Laminariae (Thallus Eckloniae), and Herba Pogostemonis can replace with Herba Eupatorii.For taking different prescriptions at the different state of an illness, thereby heighten the effect of a treatment, the present invention also can add other related drugs, as Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan, Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi, Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi etc.
In this prescription, the effect that Concha Ostreae, Sargassum, Pseudobulbus Cremastrae Seu Pleiones have softening the hard mass, eliminating stagnation, regulate the flow of vital energy; Herba Pogostemonis, Bulbus Fritillariae Thunbergii have regulate the flow of vital energy, the effect of pain relieving, damp eliminating; Rhizoma Chuanxiong has the effect of promoting the flow of QI in the collateral by warming the meridian, blood circulation promoting and blood stasis dispelling; Herba Asari, the Radix Angelicae Dahuricae have cold expelling, damp eliminating, analgesic effect; Spica Prunellae has the effect of heat-clearing and toxic substances removing.
" you are glad for the breast " capsule that adopts method provided by the invention to make has the following advantages: 1, by invigorating QI and blood, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, improve the human body metabolism thereby reach, eliminate the long-pending purpose of the stasis of blood in the body.2, regulating QI to relieve pain can be alleviated the pain that cyclomastopathy causes.3, adopting Chinese herbal medicine is raw material, has no side effect.4, by 1000 many cases clinical trials, effective percentage is 93%.5, taking convenience, cost are lower, are applicable to ordinary people.
(4) specific embodiment:, the present invention is done further narration below in conjunction with embodiment.
Embodiment 1: selecting Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, is 1 with Rhizoma Chuanxiong weight, and all the other each medical materials are followed successively by: 0.5,0.5,0.5,0.5,1,1,1,1,7,7.
During making, screen successively, operation such as rinsing, oven dry, pulverizing, dress capsule, make capsule, also can be made into tablet or pill.
Embodiment 2: selecting Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, is 1 with Rhizoma Chuanxiong weight, and all the other each medical materials are followed successively by: 1.5,1.5,1.5,1.5,3,3,3,3,9,9.
Manufacture method is with embodiment 1.
Embodiment 3: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Meretricis Seu Cyclinae, Thallus Laminariae (Thallus Eckloniae), also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.7,0.7,0.7,0.7,1.3,1.3,1.3,1.3,7.4,7.4,1.4,0.6,0.9,1.4,2.4,0.9.
Manufacture method is with embodiment 1.
Embodiment 4: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Meretricis Seu Cyclinae, Thallus Laminariae (Thallus Eckloniae), also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.3,1.3,1.3,1.3,2.7,2.7,2.7,2.7,8.4,8.4,2.6,1.8,2.1,2.6,3.6,2.1.
Manufacture method is with embodiment 1.
Embodiment 5: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.8,0.8,0.8,0.8,1.4,1.4,1.4,1.4,7.1,7.1,1.7,0.8,1.2,1.7,2.7,1.2.
Manufacture method is with embodiment 1.
Embodiment 6: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.2,1.2,1.2,1.2,2.4,2.4,2.4,2.4,8.1,8.1,2.3,1.6,1.8,2.3,3.3,1.8.
Manufacture method is with embodiment 1.
Embodiment 7: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.8,0.8,0.8,0.8,1.4,1.4,1.4,1.4,7.1,7.1,0.9,0.5,0.5,1.4,0.4,0.6,0.9,0.2.
Manufacture method is with embodiment 1.
Embodiment 8: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.2,1.2,1.2,1.2,2.4,2.4,2.4,2.4,8.1,8.1,2.1,1.5,1.5,2.6,1.5,1.8,2.1,0.9.
Manufacture method is with embodiment 1.
Embodiment 9: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.8,0.8,0.8,0.8,1.4,1.4,1.4,1.4,7.1,7.1,1.1,0.7,0.7,1.6,0.6,0.8,1.1,0.4.
Manufacture method is with embodiment 1.
Embodiment 10: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.2,1.2,1.2,1.2,2.4,2.4,2.4,2.4,8.1,8.1,1.9,1.3,1.3,2.4,1.3,1.6,1.9,0.7.
Manufacture method is with embodiment 1.
Embodiment 11: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 0.9,0.9,0.9,0.9,1.6,1.6,1.6,1.6,7.3,7.3,0.9,2.4,1.4,0.2.
Manufacture method is with embodiment 1.
Embodiment 12: select Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum, also comprise Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi in addition, with Rhizoma Chuanxiong weight is 1, and all the other each medical materials are followed successively by: 1.1,1.1,1.1,1.1,2.2,2.2,2.2,2.2,7.8,7.8,2.1,3.6,2.6,0.9.
Manufacture method is with embodiment 1.
Embodiment 13: select Rhizoma Chuanxiong 0.9g, Ramulus Cinnamomi 0.9g, Herba Asari 0.9g, Radix Angelicae Dahuricae 0.9g, Pseudobulbus Cremastrae Seu Pleiones 0.9g, Bulbus Fritillariae Thunbergii 1.7g, Spica Prunellae 1.7g, Herba Pogostemonis 1.7g, Radix Angelicae Sinensis 1.7g, Concha Ostreae 7.4g, Sargassum 7.4g, also comprise Radix Codonopsis 1.1g, Radix Astragali 2.6g, Rhizoma Atractylodis Macrocephalae 1.6g, Cortex Cinnamomi 0.4g in addition, screen successively, operation such as rinsing, oven dry, pulverizing, dress capsule, making heavily is the individual capsule of 0.5g/, also can be made into tablet or pill.
Embodiment 14: select Rhizoma Chuanxiong 1.1g, Ramulus Cinnamomi 1.1g, Herba Asari 1.1g, Radix Angelicae Dahuricae 1.1g, Pseudobulbus Cremastrae Seu Pleiones 1.1g, Bulbus Fritillariae Thunbergii 2.1g, Spica Prunellae 2.1g, Herba Pogostemonis 2.1g, Radix Angelicae Sinensis 2.1g, Concha Ostreae 7.7g, Sargassum 7.7g, also comprise Radix Codonopsis 1.9g, Radix Astragali 3.4g, Rhizoma Atractylodis Macrocephalae 2.4g, Cortex Cinnamomi 0.7g in addition, screen successively, operation such as rinsing, oven dry, pulverizing, dress capsule, making heavily is the individual capsule of 0.5g/, also can be made into tablet or pill.
In the embodiments of the invention, Concha Ostreae can replace with Concha Meretricis Seu Cyclinae or Concha Arcae, and Sargassum can replace with Thallus Laminariae (Thallus Eckloniae), and Herba Pogostemonis can replace with Herba Eupatorii.
Claims (5)
1, a kind of medicine for the treatment of cyclomastopathy, mainly form by Rhizoma Chuanxiong, Ramulus Cinnamomi, Herba Asari, the Radix Angelicae Dahuricae, Pseudobulbus Cremastrae Seu Pleiones, Bulbus Fritillariae Thunbergii, Spica Prunellae, Herba Pogostemonis, Radix Angelicae Sinensis, Concha Ostreae, Sargassum compatibility, it is characterized in that: with Rhizoma Chuanxiong weight is 1, all the other each medical materials are followed successively by, and 0.7～1.3,0.7～1.3,0.7～1.3,0.7～1.3,1.3～2.7,1.3～2.7,1.3～2.7,1.3～2.7,7.4～8.4,7.4～8.4.
2, a kind of medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: also have Radix Gentianae, Radix Scutellariae, Fructus Gardeniae, Poria, Radix Bupleuri, Cortex Moutan in addition, in the medical material that is increased, with Rhizoma Chuanxiong weight is 1, and each medical material heavily is followed successively by: 1.4～2.6,0.6～1.8,0.9～2.1,1.4～2.6,2.4～3.6,0.9～2.1.
3, a kind of medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: also comprise Spina Gleditsiae, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Cyperi, Fructus Citri Sarcodactylis, Radix Curcumae, Radix Platycodonis, Fructus Amomi in addition, with Rhizoma Chuanxiong weight is 1, and each medical material heavily is followed successively by: 0.9～2.1,0.5～1.5,0.5～1.5,1.4～2.6,0.4～1.5,0.6～1.8,0.9～2.1,0.2～0.9.
4, a kind of medicine for the treatment of cyclomastopathy according to claim 1, it is characterized in that: also comprise Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi in addition, in the medical material that is increased, be 1 with Rhizoma Chuanxiong weight, each medical material heavily is followed successively by: 0.9～2.1,2.4～3.6,1.4～2.6,0.2～0.9.
5, according to claim 1 or 2 or 3 or 4 described a kind of medicines for the treatment of cyclomastopathy, it is characterized in that: Concha Ostreae replaces with Concha Meretricis Seu Cyclinae, and Sargassum replaces with Thallus Laminariae (Thallus Eckloniae), and Herba Pogostemonis replaces with Herba Eupatorii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011253142A CN1136899C (en) | 2001-08-09 | 2001-08-09 | Chinese medicine for treating mastoplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011253142A CN1136899C (en) | 2001-08-09 | 2001-08-09 | Chinese medicine for treating mastoplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1334114A CN1334114A (en) | 2002-02-06 |
| CN1136899C true CN1136899C (en) | 2004-02-04 |
Family
ID=4665952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011253142A Expired - Fee Related CN1136899C (en) | 2001-08-09 | 2001-08-09 | Chinese medicine for treating mastoplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1136899C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536765A (en) * | 2013-10-24 | 2014-01-29 | 河南中医学院 | Traditional Chinese medicament for treating mammary gland hyperplasia in lactation period |
| CN103920100B (en) * | 2014-05-09 | 2016-09-28 | 马金风 | A kind of pharmaceutical composition treating cyclomastopathy |
| CN104998192A (en) * | 2015-07-13 | 2015-10-28 | 成都市飞龙水处理技术研究所青白江第一分所 | Internal drug for treating benign hyperplasia of mammary glands and preparation method thereof |
| CN109331129A (en) * | 2018-12-10 | 2019-02-15 | 陕西太白山天然植物开发有限公司 | A kind of Chinese medicine dietary product and preparation method thereof suitable for the proliferation of mammary gland |
-
2001
- 2001-08-09 CN CNB011253142A patent/CN1136899C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1334114A (en) | 2002-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1132643A (en) | Medicine for diseases of liver and gall | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1539441A (en) | Compounded medicine for anti pathogeny and immunoenhancement | |
| CN1269506C (en) | Prepared Chinese traditional medicine for alopecia | |
| CN100342891C (en) | Medicine composition for hypertension and its preparation thereof | |
| CN1201691A (en) | Medicine for curing encephalatrophy and preparation thereof | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN1172672A (en) | Chinese medicinal herb composition for treating cancer | |
| CN1190218C (en) | Chinese medicine for treating hyperosteogeny | |
| CN1051471C (en) | A kind of pharmaceutical composition for treating osteoporosis | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1223886A (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1105569C (en) | Medicinal composition for stasis of blood | |
| CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN102225132A (en) | Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof | |
| CN1226045C (en) | Medicine for treating headache | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN1698735A (en) | Medicine for treating psoriasis | |
| CN1060076C (en) | Gucixiao pill for removing spur | |
| CN1772100A (en) | Medicine for treating psoriasis and its prepn | |
| CN100340284C (en) | Jindan gallbladder stone dissolving capsule | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN1322558A (en) | an anti-cancer drug | |
| CN101032573A (en) | Medicine for treating psoriasis and its preparing process | |
| CN1076622C (en) | Chinese medicine for curing nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| C10 | Entry into substantive examination | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |